Disease-A-Month
Volume 52, Issue 5 , Pages 211-220 , May 2006

Micronutrient Supplements in Inflammatory Bowel Disease

References 

  1. Hanauer SB . Crohn’s disease (step up or top down therapy) . Best Pract Res Clin Gastroenterol . 2003;17(1):131–137
  2. Halliwell B , Zhao K , Whiteman M . The gastrointestinal tract (a major site of antioxidant action?) . Free Radic Res . 2000;33:819–830
  3. Siffledeen JS , Fedorak RN , Siminoski K , et al.   Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn’s disease . Clin Gastroenterol Hepatol . 2005;3(2):122–132
  4. Sharabi A , Cohen E , Sulkes J , et al.   Replacement therapy for vitamin B12 deficiency (comparison between the sublingual and oral route) . Br J Clin Pharmacol . 2003;56(6):635–638
  5. Schroder O , Mickisch O , Seidler U , et al.   Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease—a randomized, controlled, open-label, multicenter study . Am J Gastroenterol . 2005;100(10):2503–2509
  6. Den Hond E , Hiele M , Peeters M , et al.   Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn’s disease . J Parenter Enteral Nutr . 1999;23(1):7–11
  7. Wright JP , Mee AS , Parfitt A , et al.   Vitamin A therapy in patients with Crohn’s disease . Gastroenterology . 1985;88:512–514
  8. Miyachi Y , Yoshioka A , Imamura S , et al.   Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species . Gut . 1987;28(2):190–195
  9. Ahnfelt-Ronne I , Nielsen OH . The anti-inflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger . Agents Actions . 1987;21(1-2):191–194
  10. Grisham MB , Miles AM . Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions . Biochem Pharmacol . 1994;47(10):1897–1902
  11. Simmonds NJ , Millar AD , Blake DR , et al.   Antioxidant effects of aminosalicylates and potential new drugs for inflammatory bowel disease (assessment in cell-free systems and inflamed human colorectal biopsies) . Aliment Pharmacol Ther . 1999;13:363–372
  12. Jarnerot G , Strom M , Danielsson A , et al.   Allopurinol in addition to 5-aminosalicyclic acid based drugs for the maintenance treatment of ulcerative colitis . Aliment Pharmacol Ther . 2000;14:1159–1162
  13. Salim AS . Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis (a new approach) . J Lab Clin Med . 1992;119(6):710–717
  14. Hawkes ND , Richardson C , Ch’Ng CL , et al.   Enteric-release glyceryl trinitrate in active Crohn’s disease (a randomized, double-blind, placebo-controlled trial) . Aliment Pharmacol Ther . 2001;15(12):1867–1873
  15. Lapenna D , de Gioia S , Ciofani G , et al.   Antioxidant properties of omeprazole . FEBS Lett . 1996;382:189–192
  16. Wandall JH . Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b245 . Gut . 1992;33:617–621
  17. Suzuki M , Mori M , Miura S , et al.   Omeprazole attenuates oxygen-derived free radical production from human neutrophils . Free Radic Biol Med . 1996;21:727–731
  18. Biswas K , Bandyopadhyay U , Chattopadhyay I , et al.   A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical . J Biol Chem . 2003;278:10993–11001
  19. Koch TR , Yuan L-X , Petro A , et al.   Effects of omeprazole and ascorbate on gastric emptying and antioxidant levels in a mouse model of glutathione depletion . Dig Dis Sci . 2002;47:2486–2492
  20. Koch TR , Petro A , Darrabie M , et al.   Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy . Dig Dis Sci . 2005;50:86–93
  21. Aghdassi E , Wendland BE , Steinhart AH , et al.   Antioxidant vitamin supplementation in Crohn’s disease decreases oxidative stress. A randomized controlled trial . Am J Gastroenterol . 2003;98:348–353
  22. Geerling BJ , Badart-Smook A , van Deursen C , et al.   Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn’s disease in remission (effects on antioxidant status and fatty acid profile) . Inflamm Bowel Dis . 2000;6(2):77–84
  23. Niwa Y , Somiya K , Michelson A , et al.   Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disease. A preliminary study . Free Rad Res Commun . 1985;1:137–153
  24. Emerit J , Pelletier S , Tosoni-Verlignue D , et al.   Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohns disease . Free Radic Biol Med . 1989;7:145–149
  25. Seidner DL , Lashner BA , Brzezinski A , et al.   An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis (a randomized, controlled trial) . Clin Gastroenterol Hepatol . 2005;3(4):358–369
  26. Hilsden RJ , Scott CM , Verhoef MJ . Complementary medicine use by patients with inflammatory bowel disease . Am J Gastroenterol . 1998;93:697–701
  27. Rawsthorne P , Shanahan F , Cronin NC , et al.   An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease . Am J Gastroenterol . 1999;94:1298–1303
  28. Kong SC , Hurlstone DP , Pocock CY , et al.   The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases . Ali Tract (Clin Res) . 2005;39:138–141
  29. Langmead L , Dawson C , Hawkins C , et al.   Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease (an in vitro study) . Aliment Pharmacol Ther . 2002;16(2):197–205
  30. Langmead L , Rampton DS . Herbal treatment in gastrointestinal and liver disease (benefits and dangers) . Aliment Pharmacol Ther . 2001;15:1239–1252

PII: S0011-5029(06)00032-0

doi: 10.1016/j.disamonth.2006.05.008

Disease-A-Month
Volume 52, Issue 5 , Pages 211-220 , May 2006

Article Tools